DK2268605T3 - Fedtsyrederivater til oral indgivelse forsynet med høj palatabilitet - Google Patents

Fedtsyrederivater til oral indgivelse forsynet med høj palatabilitet

Info

Publication number
DK2268605T3
DK2268605T3 DK09734632.4T DK09734632T DK2268605T3 DK 2268605 T3 DK2268605 T3 DK 2268605T3 DK 09734632 T DK09734632 T DK 09734632T DK 2268605 T3 DK2268605 T3 DK 2268605T3
Authority
DK
Denmark
Prior art keywords
oral administration
acid derivatives
food acid
high palatability
administration supplied
Prior art date
Application number
DK09734632.4T
Other languages
English (en)
Inventor
Canani Roberto Berni
Antonio Calignano
Orietta Mazzoni
Anna Coruzzo
Original Assignee
Canani Roberto Berni
Antonio Calignano
Orietta Mazzoni
Anna Coruzzo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canani Roberto Berni, Antonio Calignano, Orietta Mazzoni, Anna Coruzzo filed Critical Canani Roberto Berni
Application granted granted Critical
Publication of DK2268605T3 publication Critical patent/DK2268605T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/31—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/90—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated
    • C07C233/91—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated with carbon atoms of the carboxamide groups bound to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK09734632.4T 2008-04-21 2009-04-21 Fedtsyrederivater til oral indgivelse forsynet med høj palatabilitet DK2268605T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000214A ITRM20080214A1 (it) 2008-04-21 2008-04-21 Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico.
PCT/IT2009/000179 WO2009130735A1 (en) 2008-04-21 2009-04-21 Fatty acid derivatives for oral administration endowed with high palatability

Publications (1)

Publication Number Publication Date
DK2268605T3 true DK2268605T3 (da) 2014-09-15

Family

ID=40297237

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09734632.4T DK2268605T3 (da) 2008-04-21 2009-04-21 Fedtsyrederivater til oral indgivelse forsynet med høj palatabilitet

Country Status (12)

Country Link
US (1) US9255062B2 (da)
EP (1) EP2268605B1 (da)
CN (1) CN102105436B (da)
AU (1) AU2009239330B2 (da)
CA (1) CA2721756C (da)
DK (1) DK2268605T3 (da)
ES (1) ES2498681T3 (da)
IT (1) ITRM20080214A1 (da)
NZ (1) NZ589372A (da)
PL (1) PL2268605T3 (da)
RU (1) RU2520070C2 (da)
WO (1) WO2009130735A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2014172453A2 (en) * 2013-04-16 2014-10-23 Philadelphia Health And Education Corporation D/B/A Drexel University College Of Medicine Novel compositions useful in treating brain-related diseases or disorders and methods using same
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
BR112018008726A2 (pt) * 2015-11-09 2018-10-30 Mjn Us Holdings Llc composições nutricionais contendo butirato e usos destas
US20170127693A1 (en) * 2015-11-09 2017-05-11 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
WO2018183411A1 (en) * 2017-03-28 2018-10-04 The Regents Of The University Of Michigan Small molecule dcn1 inhibitors and therapeutic methods using the same
EP3801496A4 (en) 2018-06-05 2022-07-06 Flagship Pioneering Innovations V, Inc. ACTIVE AGENTS AND METHODS OF USE THEREOF FOR TREATING METABOLIC DISORDERS AND NAFLD
WO2022106253A1 (en) 2020-11-18 2022-05-27 Dsm Ip Assets B.V. New synthesis of l-phenylalanine butyramide
IT202100009497A1 (it) 2021-04-15 2022-10-15 Rhea Innovations S R L Derivati amidici dell'acido butirrico come adiuvante nel trattamento e la prevenzione di infezione da sars-cov-2
CN113582871B (zh) * 2021-09-29 2022-01-04 北京天赋神奇科技有限公司 一种含镁水溶性欧米伽3脂肪酸

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3003898A1 (de) * 1980-02-02 1981-08-13 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur acylierung von aminocarbonsaeuren
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
RU2048807C1 (ru) * 1993-10-10 1995-11-27 Научно-исследовательская фирма "Ультрасан" Антибактериальный противовоспалительный препарат
US5880152A (en) * 1995-10-06 1999-03-09 Vertex Pharmaceuticals, Inc. Butyrate prodrugs derived from lactic acid
DE19629717C1 (de) * 1996-07-25 1998-02-12 Hoechst Ag Verfahren zur katalytischen Herstellung von N-Acylglycinderivaten
US6506786B2 (en) * 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
US20060211603A1 (en) * 2004-08-18 2006-09-21 Vicuron Pharmaceuticals Inc. Ramoplanin derivatives possessing antibacterial activity

Also Published As

Publication number Publication date
WO2009130735A4 (en) 2010-01-21
WO2009130735A8 (en) 2011-03-10
RU2520070C2 (ru) 2014-06-20
NZ589372A (en) 2013-11-29
US9255062B2 (en) 2016-02-09
ES2498681T3 (es) 2014-09-25
AU2009239330A1 (en) 2009-10-29
CA2721756A1 (en) 2009-10-29
CN102105436A (zh) 2011-06-22
RU2010147401A (ru) 2012-05-27
CN102105436B (zh) 2014-11-12
AU2009239330B2 (en) 2014-08-28
ITRM20080214A1 (it) 2009-10-22
PL2268605T3 (pl) 2015-01-30
WO2009130735A1 (en) 2009-10-29
EP2268605B1 (en) 2014-06-04
EP2268605A1 (en) 2011-01-05
CA2721756C (en) 2017-03-21
US20110098319A1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
DK2268605T3 (da) Fedtsyrederivater til oral indgivelse forsynet med høj palatabilitet
DK2328601T3 (da) Linaclotid-holdige formuleringer til oral indgivelse
IL211099A0 (en) Formulation for oral administration of proteins
BRPI0919447A2 (pt) derivados do ácido 1-amino-2-ciclobutiletilborônico
DK2420223T3 (da) Vandige farmaceutiske sammensætninger med borat-polyol-komplekser
ZA200908960B (en) Oral nicotine formulation buffered with amino acid
DK2395979T3 (da) Orale doseringssammensætninger med forsinket frigivelse, der indeholder amorft ccdo-me
DK2285359T3 (da) Lægemiddelformulering i fast form med forsinket udskillelse
BRPI1007484A2 (pt) composição farmacêutica para administração oral
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
DK2391351T3 (da) Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
IL201090A0 (en) Indolizine acetic acid derivatives as crth2 antagonists
BRPI0918539A2 (pt) preparação farmacêutica sólida para administração oral
IL206524A0 (en) 4-dimethylminobutyric acid derivatives
BRPI0919194A2 (pt) preparação sólida para administração oral
EP2219445A4 (en) INFLAMMATORY CHINIC ACID DERIVATIVES FOR ORAL ADMINISTRATION
ITFI20080016A1 (it) Formulazioni farmaceutiche orali contenenti gliclazide.
HK1209022A1 (en) Amino acid derivatives used as pharmaceutical substances
BRPI1012581A2 (pt) derivados de amidas de ácido 6, 7-di-hidro-5h-imidazol[1,2-a]imidazol-3-carboxílico
BRPI0913940A2 (pt) formulação de fenofibrato com biodisponibilidade oral aumentada
EP2337565A4 (en) STABLE SOLID ORAL CO DOSAGE FORMULATIONS
BRPI0919475A2 (pt) composição farmacêutica para administração oral
EP2343089A4 (en) USE OF XYLITOL OR DERIVATIVES THEREOF FOR MASKING THE TASTE OF CHEMOTHERAPEUTIC MEDICAMENTS OF THE CHINOLO-N-NAPHTHYRIDONE-CARBOXYLIC ACID GROUP FOR PIG DICULTINATION
HU0900482D0 (en) Pharmaceutical formulation for oral administration
EP2520300A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION